**Core Concept**
The patient's symptoms are consistent with vitiligo, a chronic autoimmune skin condition characterized by the loss of pigment-producing melanocytes, leading to depigmented patches. The treatment of vitiligo involves various modalities aimed at repigmentation, immune suppression, and camouflage.

**Why the Correct Answer is Right**
The treatment of vitiligo often involves topical corticosteroids, phototherapy, and immunomodulators. However, the use of systemic corticosteroids is generally avoided due to their potential side effects and the risk of exacerbating the condition. Systemic corticosteroids can suppress the immune system, potentially worsening the autoimmune response and leading to further depigmentation.

**Why Each Wrong Option is Incorrect**
* **Option A:** Topical corticosteroids are commonly used in the treatment of vitiligo to reduce inflammation and promote repigmentation.
* **Option B:** Phototherapy, such as ultraviolet B (UVB) light, is a standard treatment for vitiligo, as it helps to stimulate melanocyte growth and repigmentation.
* **Option C:** Immunomodulators, such as tacrolimus and pimecrolimus, are used to suppress the immune system and promote repigmentation in vitiligo patients.

**Clinical Pearl / High-Yield Fact**
It's essential to note that the treatment of vitiligo often requires a combination of therapies, and the choice of treatment depends on the severity and extent of the condition. A dermatologist should be consulted for proper evaluation and management.

**Correct Answer: D. Systemic corticosteroids.**